Analyst Coverage

Firm Analysts
Bank of America Merrill Lynch Tazeen Ahmad
Barclays Eliana Merle, CFA
Bernstein William Pickering
Cantor Fitzgerald Kristen Kluska
Citigroup Yigal D. Nochomovitz, PhD
Deutsche Bank David Hoang, M.D., Ph.D.
Evercore ISI Gavin Clark-Gartner
Goldman Sachs Salveen Richter
Guggenheim Securities, LLC Debjit Chattopadhyay, Ph.D
H.C. Wainwright & Co. Mitchell Kapoor
Jefferies LLC Andrew Tsai
J.P. Morgan Securities Anupam Rama
Leerink Partners Joseph P. Schwartz
Mizuho Securities USA LLC Uy Ear
Morgan Stanley Mike Ulz
Needham & Company Gil Blum, Ph.D
Oppenheimer & Company Kostas Biliouris, Ph.D.
Piper Sandler & Co. Biren Amin
RBC Capital Markets Brian Abrahams, M.D.
Robert W. Baird & Co. Brian Skorney, CFA
TD Cowen Ritu Baral, Ph.D.
WBB Securities, LLC Stephen G. Brozak
Wells Fargo Securities Yanan Zhu, Ph.D.
William Blair Sami Corwin, Ph.D
Wolfe Research Andy Chen, Ph.D., CFA
Wedbush Securities Yun Zhong, Ph.D.

 

Sarepta Therapeutics, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Sarepta Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Sarepta Therapeutics, Inc. or its management. Sarepta Therapeutics, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.